Navnath S. Gavande

7-Hydroxy-benzopyran-4-one Derivatives: A Novel Pharmacophore of Peroxisome Proliferator-Activated Receptor α and -γ (PPARα and γ) Dual Agonists

Azadeh Matin, Navnath S. Gavande, Moon S. Kim et al. · Journal of Medicinal Chemistry · 2009 · 89 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Regulation of Low‐Density Lipoprotein Receptor and 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Expression by <i>Zingiber officinale</i> in the Liver of High‐Fat Diet‐Fed Rats

Srinivas Nammi, Moon S. Kim, Navnath S. Gavande et al. · Basic & Clinical Pharmacology & Toxicology · 2010 · 61 citations

Life Sciences, Biochemistry, Pharmacology +16

The enantiomers of syn-2,3-difluoro-4-aminobutyric acid elicit opposite responses at the GABA_Creceptor

Izumi Yamamoto, Meredith J. T. Jordan, Navnath S. Gavande et al. · Chemical Communications · 2011 · 56 citations

Medicine, Medicinal Chemistry, Pharmacology +15

2′‐Methoxy‐6‐methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA_Areceptors

Nasiara Karim, John Curmi, Navnath S. Gavande et al. · British Journal of Pharmacology · 2011 · 50 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction

Navnath S. Gavande, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak et al. · Nucleic Acids Research · 2020 · 46 citations · Full text

Medicine, Molecular Biology, Oncology +16